These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37559877)

  • 1. The role of 3-Tesla magnetic resonance perfusion and spectroscopy in distinguishing glioblastoma from solitary brain metastasis.
    Hung ND; Dung LV; Vi NH; Hai Anh NT; Hong Phuong LT; Hieu ND; Duc NM
    J Clin Imaging Sci; 2023; 13():19. PubMed ID: 37559877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminating glioblastoma from solitary brain metastases on 3 Tesla magnetic resonance imaging: the roles of fractional anisotropy and mean diffusivity.
    Nguyen DH; Le TD; Nguyen HV; Nguyen-Thi VA; Nguyen DH; Dong-Van H; Nguyen MD
    Eur Rev Med Pharmacol Sci; 2022 Dec; 26(23):8823-8831. PubMed ID: 36524501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic algorithm for glioma grading using dynamic susceptibility contrast‑enhanced magnetic resonance perfusion and proton magnetic resonance spectroscopy.
    Nguyen DH; Nguyen DH; Le TD; Nguyen HK; Nguyen-Thi VA; Nguyen MD
    Biomed Rep; 2024 Mar; 20(3):56. PubMed ID: 38357240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
    Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
    AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of MRI perfusion and spectroscopy for brainstem glioma grading.
    Tran D; Nguyen DH; Nguyen HK; Nguyen-Thanh VA; Dong-Van H; Nguyen MD
    Eur Rev Med Pharmacol Sci; 2022 Nov; 26(21):7938-7948. PubMed ID: 36394742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis.
    Server A; Orheim TE; Graff BA; Josefsen R; Kumar T; Nakstad PH
    Neuroradiology; 2011 May; 53(5):319-30. PubMed ID: 20625709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of Glioblastoma and Solitary Brain Metastasis by Gradient of Relative Cerebral Blood Volume in the Peritumoral Brain Zone Derived from Dynamic Susceptibility Contrast Perfusion Magnetic Resonance Imaging.
    She D; Xing Z; Cao D
    J Comput Assist Tomogr; 2019; 43(1):13-17. PubMed ID: 30015801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing Tumor Recurrence From Radiation Necrosis in Treated Glioblastoma Using Multiparametric MRI.
    Feng A; Yuan P; Huang T; Li L; Lyu J
    Acad Radiol; 2022 Sep; 29(9):1320-1331. PubMed ID: 34896001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric MRI in differentiating solitary brain metastasis from high-grade glioma: diagnostic value of the combined use of diffusion-weighted imaging, dynamic susceptibility contrast imaging, and magnetic resonance spectroscopy parameters.
    Aslan K; Gunbey HP; Tomak L; Incesu L
    Neurol Neurochir Pol; 2019; 53(3):227-237. PubMed ID: 31180131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfusion Computed Tomography Parameters Are Useful for Differentiating Glioblastoma, Lymphoma, and Metastasis.
    Onishi S; Kajiwara Y; Takayasu T; Kolakshyapati M; Ishifuro M; Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Yamasaki F
    World Neurosurg; 2018 Nov; 119():e890-e897. PubMed ID: 30099179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling.
    Huang J; Wang AM; Shetty A; Maitz AH; Yan D; Doyle D; Richey K; Park S; Pieper DR; Chen PY; Grills IS
    Magn Reson Imaging; 2011 Sep; 29(7):993-1001. PubMed ID: 21571478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of MRSI Major Metabolite Ratios in Differentiating Between Intracerebral Ring-Enhancing Neoplastic and Non-Neoplastic Lesions, High-Grade Gliomas and Metastases, and High-Grade and Low-Grade Gliomas.
    Ankush A; Sardessai S
    Cureus; 2022 Nov; 14(11):e31841. PubMed ID: 36579207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrimination between glioblastoma and solitary brain metastasis: a quantitative analysis based on FLAIR signal intensity.
    Nguyen DH; Nguyen DM; Nguyen HV; Nguyen-Thi VA; Nguyen-Thi HA; Nguyen TX; Nguyen MD
    Eur Rev Med Pharmacol Sci; 2022 May; 26(10):3577-3584. PubMed ID: 35647839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects.
    Fink JR; Carr RB; Matsusue E; Iyer RS; Rockhill JK; Haynor DR; Maravilla KR
    J Magn Reson Imaging; 2012 Jan; 35(1):56-63. PubMed ID: 22002882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrimination between Glioblastoma and Solitary Brain Metastasis: Comparison of Inflow-Based Vascular-Space-Occupancy and Dynamic Susceptibility Contrast MR Imaging.
    Li X; Wang D; Liao S; Guo L; Xiao X; Liu X; Xu Y; Hua J; Pillai JJ; Wu Y
    AJNR Am J Neuroradiol; 2020 Apr; 41(4):583-590. PubMed ID: 32139428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major Metabolite Levels of Preoperative Proton Magnetic Resonance Sectroscopy and Intraoperative Fluorescence Intensity in Glioblastoma.
    Tian HL; Zu YL; Wang CC; Lin T; Guo ZT; Jiang B; Yin X; Guo WQ; Wang ZG
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):511-517. PubMed ID: 28877829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can proton MR spectroscopic and perfusion imaging differentiate between neoplastic and nonneoplastic brain lesions in adults?
    Hourani R; Brant LJ; Rizk T; Weingart JD; Barker PB; Horská A
    AJNR Am J Neuroradiol; 2008 Feb; 29(2):366-72. PubMed ID: 18055564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.